While the Windows maker did not attribute the activity to a specific threat actor, the use of VS Code tasks and Vercel ...
As your business grows, HR complexity increases. See how combining scalable HR technology with expert guidance helps ...
A mum-of-three left in "constant, disabling pain" after an operation says women like her should not suffer in silence. Kerry ...
HCPs and key opinion leaders (KOLs) have always been central to the success of new therapies, shaping how innovations reach patients and influencing the trajectory of scientific understanding within ...
Taiwan is such a place. Despite being home to only about 23 million people, Taiwan is a vital gateway to the western Pacific. It sits along maritime routes essential to global trade and is a leader in ...
News from the week beginning 23rd February included items from @Workday, @ThomsonReuters, @Sirion, @Rootstock, @Nintex, ...
Ukraine has been putting up valiant resistance, but its determination cannot disguise the fact that it is losing the war. Russia controls a large swath of Ukrainian territory, and Kyiv has little ...
A recent exchange on LinkedIn about the EMS industry got me thinking about the many good, bad and ugly NPI processes I have ...
AI isn’t just helping out with coding — it’s helping complete entire projects at a pace and price-point that would’ve been unthinkable ...
Cyber Daily was a guest at Genetec’s recent Global Press Summit 2026 – here’s what we learned about the company and how it sees itself in the 21st century.
Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results